Great West Life Assurance CO Catalyst Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 140,939 shares of CPRX stock, worth $2.88 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140,939
Previous 147,245
4.28%
Holding current value
$2.88 Million
Previous $2.35 Million
6.99%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CPRX
# of Institutions
285Shares Held
96.6MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$382 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$187 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$166 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$123 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$61.3 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.1B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...